Search

Released in partnership with the Desert Research Institute: New research from the Healthy Nevada Project® finds that a confirmed diagnosis does not always result in changes to patient care. Presenting individuals with potentially life-altering health information doesn’t mean the individuals – or their healthcare providers – will act on it. Follow-up education and conversations about actionable care plans with patients and their doctors are key next steps, according to new research from the Healthy Nevada Project.  The Healthy Nevada Project is a genetic screening and research project that launched in 2016 as a partnership between DRI and Renown Health. The project now has more than 50,000 participants, with genetic sequencing provided by Helix.  Between September 2018 and September 2020, the Healthy Nevada Project successfully notified 293 participants that they were genetically at risk for hereditary breast and ovarian cancer syndrome, Lynch syndrome, or familial hypercholesterolemia – three common genetic conditions known collectively as the Centers for Disease Control and Prevention (CDC) Tier 1 conditions. In a study published today in Frontiers in Genetics, Healthy Nevada Project scientists looked at the impact that notifying a patient of a positive finding for a CDC Tier 1 condition had on the care that the patient received in the months and years that followed.  According to their results, among the 293 Healthy Nevada Project participants who were notified of their genetic risk of a CDC Tier 1 condition, 71 percent of participants with electronic health records shared their findings with healthcare providers. However, only 30 percent of the electronic health records for these patients contained documentation of the genetic diagnosis, and only 10 percent of examined patients experienced a possible change in care after receiving the results of their genetic screening.  “The Healthy Nevada Project was implemented with a ‘hands-off’ approach where the participants receive their findings and decide with whom and when to share those findings. The findings were not automatically added to their electronic health records,” said Dr. Gai Elhanan, health data scientist at DRI and co-lead author of the study. “What we’re learning now is that to ensure that important genetic findings are integrated into the care journey it is important to make their inclusion into the electronic health records part of the study.” This study builds on previous Healthy Nevada Project research published in Nature Medicine demonstrating the importance of screening for CDC Tier 1 conditions, which affect about one in 75 individuals and can be mitigated or even prevented from developing into disease when detected early. This study found that as many as 90 percent of the CDC Tier 1 cases are missed by clinical providers during normal clinical care screenings and examinations. During the current study, the Healthy Nevada Project scientists found that 19 percent of studied participants had already developed one of the CDC Tier 1 conditions, and thus would have potentially benefited from earlier notification about their condition. The study team hopes that their findings will encourage individuals in Nevada to obtain genetic testing for these relatively common conditions. Even if individuals are older or have already suffered from diseases related to these conditions, testing could also prove beneficial to siblings, children, and grandchildren who may also be at risk and who could subsequently be screened in the event of a positive finding. The study team also encourages informing health care providers of the importance of incorporating genetic diagnoses into the pharmaceutical (for example, for Familial Hypercholesterolemia) and treatment advice given to patients.  “As a result of this analysis, the clinicians at Renown Health and the Healthy Nevada Project researchers have made significant changes, including obtaining informed consent from participants to report positive findings from their genetics reports directly into their electronic medical record,” said Daniel Kiser, M.S., assistant research scientist of data science at DRI and co-lead author of the study. “This will help both participants, their clinical providers, and the whole state maximize the long-term benefits of the Healthy Nevada Project voluntary population-based genetic screening.” Additional information: The full text of the study,  Incomplete Penetrance of Population-Based Genetic Screening Results in Electronic Health Record, is available from Frontiers in Genetics: https://www.frontiersin.org/articles/10.3389/fgene.2022.866169/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Genetics&id=866169.  This project was funded by Renown Health, the Renown Health Foundation, and the Nevada Governor’s Office of Economic Development. Study authors included Gai Elhanan (DRI), Daniel Kiser (DRI), Iva Neveux (DRI), Shaun Dabe (Renown Health), Alexander Bolze (Helix), William Metcalf (DRI), James Lu (Helix), and Joseph Grzymski (DRI/Renown Health). For more information on the Healthy Nevada Project® or to request genetic screening, please visit: https://healthynv.org/ About DRI The Desert Research Institute (DRI) is a recognized world leader in basic and applied environmental research. Committed to scientific excellence and integrity, DRI faculty, students who work alongside them, and staff have developed scientific knowledge and innovative technologies in research projects around the globe. Since 1959, DRI’s research has advanced scientific knowledge on topics ranging from humans’ impact on the environment to the environment’s impact on humans. DRI’s impactful science and inspiring solutions support Nevada’s diverse economy, provide science-based educational opportunities, and inform policymakers, business leaders, and community members. With campuses in Las Vegas and Reno, DRI serves as the non-profit research arm of the Nevada System of Higher Education. For more information, please visit www.dri.edu. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision making. Learn more at www.helix.com.

Read More About Study Shows Importance of Ensuring Participant and Provider Follow-up After a Genetic Screening Result

Paul J. Hauptman, MD, has been named Dean of The University of Nevada, Reno School of Medicine and Chief Academic Officer for Renown Health. Dr. Hauptman is a nationally recognized investigator in outcomes assessment in advanced heart failure, the evaluation of cardiac care delivery and clinical trials. Dr. Hauptman currently serves as Dean at the University of Tennessee Graduate School of Medicine-Knoxville and Chief Academic Officer at the University of Tennessee Medical Center. He begins his appointment on Oct. 17, 2022. The selection of Dr. Hauptman came following a nationwide search. “Dr. Hauptman has an impeccable background in all of the areas that we felt were essential in finding our new Dean,” University President Brian Sandoval said. “He has a passion for and a deep understanding of how we should be training Nevada’s next generation of physicians. He has vast experience in administering and delivering clinical programs that can have a profound impact on our local communities. He has incredible credentials in the research arena. He clearly articulated a compelling vision on how he hopes to magnify and grow the educational and research endeavors of our School of Medicine. Equally important, it was very clear that he felt that as we expand upon current educational and research initiatives to enhance our School of Medicine’s impact, he is committed to working collaboratively across the community in order to meet its greatest needs. On behalf of the entire University, we are excited to have Dr. Hauptman as our new dean. We want to offer Dr. Hauptman and his family a warm welcome to the Wolf Pack Family.” "The appointment of Dr. Paul Hauptman as dean is a great step forward for the Medical School and for Renown Health. His record of leadership, scholarship, scientific expertise and enthusiasm in building academic and clinical excellence, creates an even higher standard for medical education and quality health care in the next decade. In addition to his talent as a physician and professor, Paul brings a deep humanity and commitment to the study and practice of medicine. We are pleased to welcome Dr. Hauptman to Nevada and know he will do much to advance health and health care through world-class medical education, clinical research and patient care for our community and our state,” said Thomas R. Graf, MD, FAAFP, Chief Executive Officer of Renown Health. Dr Graf also serves as Chief Clinical and Quality Officer at Renown, and Senior Associate Dean for Clinical Affairs for University of Nevada, Reno School of Medicine. As Dean and Chief Academic Officer, Dr. Hauptman will support and advance the academic and clinical integration established under the affiliation between UNR Med and Renown Health. This affiliation benefits the community by recruiting top-tier physicians and health care professionals, improving access to and developing new models of innovative care, and investing in clinical research. As pillars of health care in northern Nevada, both organizations provide key services for underserved populations, and collaborate to educate, train and employ the next generation of doctors and health care professionals. Together, they support the health of local and rural communities, the state and the nation. “I am delighted to have this opportunity and honored to lead the School of Medicine and the academic mission of Renown Health for the betterment of our students, trainees, physicians, patients and community-at-large. This is a pivotal time for medical education and the delivery of quality healthcare, and I will be steadfast in ensuring student success and the growth of research that can meaningfully impact patients. I will do my best to build upon the legacy of Dr. Schwenk and look forward to collaborating with President Sandoval, Provost Thompson, and Dr. Graf and the Renown team. I am all in for the silver and blue – and purple!” A first-generation American and college graduate, Dr. Hauptman received his M.D. degree from Cornell University Medical College (now Weill Medical College) and completed his internal medicine training at Brigham and Women’s Hospital/Harvard Medical School in Boston and cardiology fellowships at both Mount Sinai Hospital (New York) and Brigham and Women’s. Dr. Hauptman was on faculty at Harvard Medical School and an attending physician in the Division of Cardiology at the Brigham (1993-1998) and subsequently served as Director of Heart Failure & Transplant and Assistant Dean of Clinical and Translational Research at Saint Louis University School of Medicine, where he held an adjunct position at the College for Public Health. .Program Advancing Access to Careers in Science Scholars fund, Disparities Awareness Month and the Women in ScienceHe has received research grants from the American Heart Association and National Institutes of Health and has served as a reviewer for the National Heart, Lung and Blood Institute and as a consultant to the Circulatory System Devices Panel and Medical Device Advisory Committee of the FDA. He also has extensive clinical trial experience as site Principal Investigator and an active member of steering, clinical events and data & safety monitoring committees. He previously worked as the part-time Medical Director of a medical device company (Biocontrol Medical, 2007-2011). After serving as Associate Editor at the European Journal of Heart Failure and Circulation: Heart Failure, he was Editor-in-Chief of the Journal of Cardiac Failure for six years (2015-2020). At the University of Tennessee, Dr. Hauptman has been deeply invested in the expansion of research capabilities, faculty development and health equity issues through initiatives such as the Academic Leadership Academy, a  In recognition of his work as a mentor and patient advocate, Dr. Hauptman was named Teacher of the Year and received the Caring Physician Award from Saint Louis University. His major research interests have involved the assessment of outcomes in advanced heart failure, patient-physician communication and trends in cardiovascular care. He is the author of numerous abstracts, articles, book chapters, consensus guidelines and reviews. About UNR Med & Renown Health The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu. Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

Read More About Paul Hauptman, MD, Named Dean of The University of Nevada, Reno School of Medicine and Chief Academic Officer for Renown Health

The University of Nevada, Reno School of Medicine (UNR Med) and Renown Health are pleased to announce members of the first resident class of the new UNR Med Pediatric Residency Program. The four new Pediatric Residents will be working at Renown Children’s Hospital and in Renown outpatient pediatric clinics starting on July 1, 2023. The following four residents have matched.    Megan Dinges  Megan spent her childhood in Omaha, attending college at the University of Nebraska and medical school at the Des Moines University College of Osteopathic Medicine in Iowa. Megan is a passionate patient advocate with clinical care experience as a Certified Nursing Assistant and ICU tech prior to medical school. She has been a leader amongst peers and volunteered in a homeless shelter working with children. Megan is a first-generation college graduate.  Jason Lundy, DO  Dr. Lundy was raised in California, attending UC Santa Barbara for undergraduate school, and completing graduate school at San Diego State University with a Chemistry degree. He completed his medical training at the Alabama College of Osteopathic Medicine and is currently doing a preliminary intern year in surgery in Cincinnati, Ohio. Jason realized that his true love is Pediatrics after having two small children of his own.  Krista Luntsford, DO  Dr. Luntsford graduated from the Pacific Northwest University of Health Sciences College of Osteopathic Medicine with her Doctor of Osteopathic Medicine (DO) in 2022 and is currently completing a transitional year in surgery in New Jersey. Notably, she was awarded the Gold Humanism Award, served in student government, and led the Pediatrics Club in medical school. Originally from Washington state, she is excited to return to the west coast. Erin Whepley  Erin grew up in Kansas, attended the University of Puget Sound for undergraduate school and will be graduating with her Doctor of Medicine degree from the University of Kansas School of Medicine this spring. Erin is resilient and inspiring and has always known that she wants to serve others through pediatrics.  These four newly trained physicians will be the inaugural members and first class of the new three-year Pediatrics Residency Program with the Accreditation Council for Graduate Medical Education (ACGME) that announced last September. The residency will help shape future pediatric practices – and fill a state and nation-wide physician specialist shortage. Over a three-year period, four physicians will be selected each year for a total complement of twelve residents over a three-year period.  “This new residency is an opportunity to train the next generation of pediatricians who will want to continue providing care in northern Nevada,” said Kristina Deeter, M.D., MBA, FAAP, UNR Med Chair of Pediatrics and Physician-in-Chief at Renown Children’s Hospital. “Our community continues to grow. This new Pediatric residency-training program allows Nevada to have a supply of outstanding, compassionate physicians, now and into the future. With our exceptional team of existing pediatricians, pediatric specialists, medical teams and support staff, we are committed to providing a comprehensive and rewarding educational experience for our trainees.” “Creating a Pediatric Residency Program for our community has been a dream more than five years in the making,” says Dr. Deeter, “Formerly, UNR Med students interested in becoming pediatricians had to leave the state to complete their residency training elsewhere. This program creates a pipeline of much needed pediatricians for our state-especially under-served and rural areas – to serve vulnerable children and families of Nevada with high quality, affordable care.”  The vision to grow pediatric services into a full-fledged Children’s Hospital with a robust Department of Pediatrics as academic partner in Reno began in 2014. Today, 100,000 area children now have access to more than 60 pediatricians, including those specializing in adolescent medicine; anesthesia; cardiology; craniofacial surgery; dentistry; ear, nose and throat conditions; emergency medicine; endocrinology; gastroenterology;  general pediatrics; hospitalist medicine; intensive care; neonatology; neurology; oncology; ophthalmology;  orthopedics; psychiatry; psychology; pulmonology; surgery; urology and other subspecialties previously lacking in the community, as well as a pediatric emergency room, pediatric ICU and contemporary healthcare services at Renown Children’s Hospital. Prior to 2016, about 30% of all pediatric patients had to leave northern Nevada to receive the specialty care they needed. Now, Renown estimates that 97% of all pediatric patients and their families can receive both general and specialty pediatric care locally. The next nearest children’s hospital in the state is 7 hours or 438 miles away in Las Vegas. Paul Hauptman, MD, Dean of the University of Nevada, Reno School of Medicine, and Chief Academic Officer for Renown, explains, “Residencies are specialty training programs for doctors after they graduate from medical school. Before becoming licensed physicians, medical school graduates train for three or more years learning from more experienced ‘attending’ physicians.”  He adds, “Our new pediatric residency program is a tremendous step forward for the UNR Med and Renown Health affiliation- and for our entire community. It advances a mutual commitment to recruit and retain skilled and compassionate physicians and health care professionals, improves access to health care, and invests in clinical research that improves the health of this generation and the next. Within the UNR Med-Renown affiliation, we created an integrated Graduate Medical Education Consortium Council (GME-CC) to provide strategic oversight and growth of residency programs within the affiliation. In this agreement, UNR Med is the sponsoring institution for accreditation and Renown Health (and the VA) is the clinical training partner. This is a great addition to our existing residencies at UNR Med, which include family medicine, internal medicine, psychiatry and behavioral sciences, and provides our students with a great training opportunity in pediatrics.” Nevada’s shortage; ranks 45th for physicians and 47th in the U.S. for pediatricians.  Nevada faces a severe physician workforce shortage, ranking 45th in the nation for active physicians per 100,000 people. The physician workforce shortage is especially critical for pediatricians, with Nevada ranking 47th in the country with fewer than 10 pediatricians for every 100,000 people. The northern Nevada community is growing rapidly and Washoe County faces additional pediatrician shortages as local physicians approach retirement.  “It truly is a dream come true. Dr. Deeter and I are indebted to the comprehensive team that has built the structure, recruited faculty to support the training program and successfully recruited a Program Director, Dr. Caroline Barangan, and Associate Program Director, Dr. Shilpi Garg, a 2012 UNR Med alumna (’12), and Pediatric Residency Coordinator, Jorge Pulido-Rubio. Their hard work and time spent has ensured a successful match.” says Lawrence Duncan, M.S., VP and Administrator for Renown Women & Children’s Hospital.  “Residency programs in pediatrics recruit and train students completing medical school and seeking residency training to become a pediatrician,” says Caroline Barangan, MD, Pediatric Residency Program Director, Renown Health and UNR Med. “Workforce research consistently shows that students who complete a residency tend to stay and practice in the communities where they completed their residency training program. For those who complete medical school and residency in the same place, over 75% stay to practice in that community.” “This new community-based program will provide residents with a strong foundation in primary care pediatrics as well as broad, in-depth exposure to all pediatric subspecialties. This will create graduates equally well prepared for careers in general pediatric practice, service to the state’s rural and underserved communities or in academics," adds David Carlson, MD, UNR Med Associate Dean, Graduate Medical Education; Designated Institutional Officer. “Through the program, pediatric residents will spend their 36-month residency focused on children’s care and complete a primary care-focused clinical training program with rotations that allow them to learn while caring for children in both inpatient and outpatient settings with supervising pediatricians and pediatric specialists at Renown Children’s Hospital.”  “The Pediatrics Residency Program is a wonderful opportunity to continue a tradition of academic excellence alongside Renown Health’s record of clinical excellence,” said Brian Sandoval, President, University of Nevada, Reno. “This is one more way our affiliation, signed in 2021 to establish the first fully integrated health system in Nevada, is helping to expand clinical training and clinical research programs as well as improve access to clinical care for all Nevadans.”  “We are proud to partner with UNR Med to bring this new residency program to our community,” says Brian Erling, MD, MBA, Chief Executive Officer, Renown Health, “Attracting and retaining talent is a key component of our drive for excellence and our mutual goal of improving the health of our community. We are fortunate to have the strong infrastructure necessary to create this program and a team of highly-skilled physicians who can train the next generation of pediatricians.”  For the 2023 residency application cycle, UNR Medicine participated in the National Resident Matching Program (NRMP) and encourages applicants to visit the UNR Med GME website for more information.  About the University of Nevada, Reno School of Medicine The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu. About Renown Health Renown Health is Nevada’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,200 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently hiring exceptional members to join our team. For more information, visit renown.org.

Read More About First Pediatric Physician Residents Accepted Into New Program

The University of Nevada, Reno School of Medicine (UNR Med) and Renown Health are pleased to announce the accreditation of a new three-year Pediatrics Residency Program with the Accreditation Council for Graduate Medical Education (ACGME). The inaugural cohort of pediatric residents will start next summer, in July of 2023. The new residency will help shape future pediatric practices – and fill a state and nation-wide physician specialist shortage. Over a three-year period, four newly trained physicians will be selected each year for a total complement of twelve residents. “Creating a Pediatric Residency Program for our community has been a dream more than five years in the making,” says Max Coppes, MD, PhD, MBA, former Nell J. Redfield Chair of Pediatrics at the UNR Med and pediatrician-in-chief at Renown Children’s Hospital. “Currently, UNR Med students interested in becoming pediatricians must leave the area to complete their residency training elsewhere. The William N. Pennington Foundation has paved the way for this program, which will create a pipeline of much-needed pediatricians for our state, especially in under-served and rural areas – to serve vulnerable children and families of Nevada with high-quality, affordable care.” The vision to grow pediatric services into a full-fledged children’s hospital with a robust academic department of pediatrics in Reno began in 2014 when Renown Health and UNR Med agreed to recruit an academic pediatrician who would serve both as Chair of Pediatrics at UNR Med and as Pediatrician-in-Chief of Renown Children’s Hospital. The Nell J. Redfield Foundation donated $1.5M towards this initiative and expressed the hope to see a pediatric residency program established for the community. After the recruitment of Dr. Max Coppes for this role in 2016, The William N. Pennington Foundation recognized the need for enhanced care and expertise for pediatrics and donated $7.5 million to Renown Children’s Hospital to establish the William N. Pennington Fund for Advanced Pediatric Care. Through these gifts, 100,000 area children now have access to more than 15 specialized pediatricians, including those specializing in oncology, orthopedics, pulmonology, emergency medicine, urology and other subspecialties previously lacking in the community, as well as a pediatric emergency room, pediatric ICU and contemporary healthcare services at Renown Children’s Hospital. Prior to 2016, about 30%of all pediatric patients had to leave northern Nevada to receive the specialty care they needed. Now, thanks to donor support, Renown estimates that 97% of all pediatric patients and their families can receive both general and specialty pediatric care locally. The next nearest children’s hospital in the state is 7 hours or 438 miles away in Las Vegas. Melissa Piasecki, MD, Acting Dean of UNR Med and Chief Academic Officer for Renown, explains, “Residencies are specialty training programs for doctors after they graduate from medical school. Before becoming licensed physicians, medical school graduates train for three or more years learning from more experienced attending physicians.” She adds, “This new residency is a tremendous step forward for the UNR Med and Renown Health affiliation – and for our entire community. This pediatric residency program advances a mutual commitment to recruit and retain skilled and compassionate physicians and healthcare professionals, improve access to healthcare and invest in clinical research that improves the health of this generation and the next. Within the UNR Med andRenown affiliation, we created an integrated Graduate Medical Education Consortium Council (GME-CC) to provide strategic oversight and growth of residency programs within the affiliation. In this agreement, UNR Med is the sponsoring institution for accreditation and Renown Health and the VA are the clinical training partners. The process moved so smoothly; within six months of the affiliation, the GME-CC voted to support a new pediatric residency. This is a great addition to our existing residencies at UNR Med, which include family medicine, internal medicine, psychiatry and behavioral sciences, and provides our students with a great training opportunity in pediatrics.” Nevada faces a severe physician workforce shortage, ranking 45th in the nation for active physicians per 100,000 people. The physician workforce shortage is especially critical for pediatricians, with Nevada ranking 47th in the country with fewer than 10 pediatricians for every 100,000 people. The northern Nevada community is growing rapidly and Washoe County faces additional pediatrician shortages as local physicians approach retirement. “This new residency is an opportunity to train the next generation of pediatricians who will want to continue providing care in northern Nevada,” said Kristina Deeter, MD, MBA, FAAP, Interim UNR Med Chair of Pediatrics and Physician-in-Chief at Renown Children’s Hospital. “Our community continues to grow. This new pediatric residency-training program will allow Nevada to have a supply of outstanding, compassionate physicians, now and into the future. With our exceptional team of existing pediatricians, pediatric specialists, medical teams and support staff, we are committed to providing a comprehensive and rewarding educational experience for our trainees.” “It truly is a dream come true. We are indebted to the comprehensive team that has built the structure, recruited faculty to support the training program and successfully recruited a Program Director, Dr. Caroline Barangan, and Associate Program Director, Dr. Shilpi Garg, a 2012 UNR Med alumna,” says Lawrence Duncan, MS, VP and Administrator for Renown Women & Children’s Hospital. “Between now and summer 2023, we will add the foundational pieces needed to ensure the success of the program including recruiting a Chief Resident, ongoing faculty development and ensuring that all components are in place for recruiting, teaching, supervising and mentoring residents.” “One of the main obstacles for increasing the number of physicians to care for our growing community is the relative lack of pediatric residency programs in the state and the absence of a program in northern Nevada. Residency programs in pediatrics recruit and train students completing medical school and seeking residency training to become a pediatrician,” says Caroline Barangan, MD, Pediatric Residency Program Director, Renown Health and UNR Med. “Workforce research consistently shows that students who complete a residency tend to stay and practice in the communities where they completed their residency training program. For those who complete medical school and residency in the same place, over 75% stay to practice in that community.” “In August, recognizing the need to grow the state’s physician workforce in high-needs specialties, Nevada Governor Steve Sisolak and the Office of Science, Innovation and Technology announced the funding of five graduate medical education residency and fellowship programs, including $870,433 for the UNR Med Pediatrics Residency Program,” said Christine Bosse, Chief Government Affairs Officer for Renown Health. “Nevada produces more undergraduate medical students than it has available residencies and fellowships. Additionally, Nevada lacks fellowships in some specialties that are of interest to students. As a result, many highly educated students must leave the state for further training at a time when they are beginning real-world application of their advanced education. We appreciate that the GME Grant funding will assist the state and our community, in attracting, educating and retaining more doctors for Nevada.” “This new community-based program will provide residents with a strong foundation in primary care pediatrics as well as broad, in-depth exposure to all pediatric subspecialties. This will create graduates equally well prepared for careers in general pediatric practice, service to the state’s rural and underserved communities or in academics," adds David Carlson, MD, UNR Med Associate Dean, Graduate Medical Education, Designated Institutional Officer. “Through the program, pediatric residents will spend their 36-month residency focused on children’s care and complete a primary care-focused clinical training program with rotations that allow them to learn while caring for children in both inpatient and outpatient settings with supervising pediatricians and pediatric specialists at Renown Children’s Hospital.” “The Pediatrics Residency Program is a wonderful opportunity to continue a tradition of academic excellence alongside Renown Health’s record of clinical excellence,” said Brian Sandoval, President, University of Nevada, Reno. “This is one more way our affiliation, signed in 2021 to establish the first fully integrated health system in Nevada, is helping to expand clinical training and clinical research programs as well as improve access to clinical care for all Nevadans.” “We are proud to partner with UNR Med to bring this new residency program to our community,” says Thomas Graf, MD, interim Chief Executive Officer, Renown Health, “Attracting and retaining talent is a key component of our drive for excellence as a care leader and our mutual goal of improving the health of our community. We are fortunate to have the strong infrastructure necessary to create this program and a team of highly-skilled physicians who can train the next generation of pediatricians.” For the 2023 residency application cycle, UNR Med will participate in the National Resident Matching Program (NRMP) and encourages applicants to visit the UNR Med GME website for more information.  About UNR Med The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu. About Renown Health Renown Health is Nevada’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 6,500 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®.

Read More About Approval of New Pediatric Physician Residency Program Helps Improve Care for Children and Families in Nevada

Medical Students Recognize Transgender Lives Lost to Violence, Address Inequities in Health The month of November includes Transgender Awareness Week, which concludes with Transgender Day of Remembrance (TDOR), on Sunday, November 20, a day for people to come together to recognize the many transgender lives lost to violence over the last year. Transgender people remain one of the most underserved groups of people across several domains, including health care. The Transgender Day of Remembrance and Resilience memorializes people who have passed due to transphobic violence. The Transgender community is an umbrella term used by people who do not identify with the gender associated with the sex they were assigned at birth. Not everyone identifies with the term transgender, and there are many self-identifier terms for people who do not identify with their assigned sex at birth (e.g., woman, man, trans, non-binary, gender nonconforming, gender fluid, gender queer, and more). Transgender Day of Remembrance is held in November to honor Rita Hester, whose murder on Nov. 28, 1998, launched the “Remembering Our Dead” web project and a San Francisco vigil the following year. The event provides a forum for transgender communities and allies to raise awareness of the threat of violence faced by gender variant people and the persistence of prejudice felt by the transgender community. Communities organize events and activities including town hall style "teach-ins," photography and poetry exhibits and candlelit vigils. These activities make anti-transgender violence visible to stakeholders like police, the media, and elected officials. In 2010, TDoR was observed in over 185 cities throughout more than 20 countries. Here in Reno, the University of Nevada, Reno School of Medicine (UNR Med) hosts Diversity Dialogues, a series hosted by the Office of Diversity and Inclusion. This month, the Medical Student Pride Alliance of UNR Med honored transgender people whose lives were lost in acts of anti-transgender violence, that included a medical student-led discussion regarding ways to help raise visibility and awareness for transgender people and the issues faced by the community. Diversity Dialogues is an open discussion of diversity and inclusion issues and the diversity initiatives at UNR Med. The UNR Med Diversity Dialogues included a reading of the names of those who died from October 1st of the former year to September 30th of the current year, and education on transgender and gender non-conforming people. Medical students recommend ways that healthcare providers can help support the community including: Being open to feedback, criticism, and new information Contributing to a LGBTQ+ safe space by using pronoun pins, flags, inclusive language Registering your practice on Nevada Gender Affirming Healthcare Project (NGAHP), GLMA: Health Professionals Advancing LGBTQ Equality, Outcare Health, & other provider lists Reading new research in academic journals and stay up to date with guidelines including World Professional Association for Transgender Health (WPATH) Version 8 and attending CME courses on LGBTQ+ Care. The general public can support the community by: Standing up for trans people in your life, in the media, and amongst your peers, and be an active, proud ally to the community Respecting people’s identities and fluidity and learn to use different pronouns Consuming trans-friendly and LGBTQ+ friendly media (tv shows, movies, music, podcasts) Following trans people on social media, specifically activists/educators, to learn from them This month, the Human Rights Campaign (HRC) Foundation, the educational arm of the Human Rights Campaign, the nation’s largest lesbian, gay, bisexual, transgender and queer (LGBTQ+) civil rights organization, released “An Epidemic of Violence: Fatal Violence Against Transgender and Gender Non-Conforming People in the United States in 2022” a report honoring the lives of at least 32 transgender and gender non-conforming people killed in 2022 and shining a light on data that HRC has continued to collect on the epidemic of violence. HRC has officially recorded at least 300 violent deaths of transgender and gender non-conforming people, including 32 in 2022 alone, since the organization began tracking this violence ten years ago. Overall, transgender and gender non-conforming victims of violence are overwhelmingly Black, under 35, and killed with a firearm. The highest known single-year total of fatal deaths of transgender and gender non-conforming people was in 2021, when at least 57 trans & gender non-conforming people were violently killed. Worse, these disturbing numbers likely underreport the deadly violence targeting transgender and gender non-confirming people, who may not be properly identified as transgender or gender non-conforming by police, media or other sources. In 2022, the Human Rights Campaign Foundation recognized Renown Regional Medical Center in Reno, Nev. as the first and only hospital in Nevada at the highest level of support as “LGBTQ+ Healthcare Equality Leader.” The Healthcare Equality Index (HEI) is the nation’s foremost benchmarking survey of healthcare facilities on policies and practices dedicated to the equitable treatment and inclusion of LGBTQ+ patients, visitors and employees. For more on LBGTQ+ care and providers at Renown, visit renown.org/diversity/lgbtq-at-renown/. The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu. Renown Health is Nevada's largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children's hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health.

Read More About UNR Med and Renown Health Recognize Transgender Day of Remembrance

Together, will test over 30,000 qualifying study participants by 2023 for risk of cirrhosis and liver-related illnesses. Renown Institute for Health Innovation (IHI) announced today that the organization and Gilead Sciences, Inc. will be joining forces with Siemens Healthineers to offer the Enhanced Liver Fibrosis (ELF™) Test to people with risks for nonalcoholic steatohepatitis (NASH) enrolled in the Healthy Nevada Project (HNP). The ELF Test will help identify people most at risk for progressing to cirrhosis and liver-related outcomes and allow healthcare providers to intervene before irreparable damage occurs. This noninvasive blood test uses three serum biomarkers to create an ELF score from a predefined algorithm, which can be used by doctors to help evaluate if a patient requires increased medical care and monitoring for their condition. Nonalcoholic fatty liver disease (NAFLD), which includes NASH, is prevalent in Nevada and under-diagnosed, likely affecting more than 500,000 adult Nevadans. If undetected and untreated, NASH can result in liver cirrhosis and may require liver transplantation or lead to death. There are more than 12,000 people on a waitlist for liver transplantation in the U.S. and this number continues to rise due to the increasing prevalence of NAFLD. “Thanks to important data collected through our Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study, we now know that NASH is prevalent in the state of Nevada,” said Tony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health. “We are proud to expand our partnership with Gilead and begin working with Siemens Healthineers to improve health of those with liver disease and to take early detection one step further by offering Enhanced Liver Fibrosis, ELF testing for patients of Renown Health. This test provides our team of highly-skilled physicians an advanced, noninvasive method to actively assess dynamic liver fibrosis in study participants and intervene whenever necessary, contributing to a healthier Nevada.”  “Gilead believes that noninvasive tests, including the ELF Test, will help improve the experience of people living with NASH. These tests may help to diagnose liver disease, monitor disease progression and evaluate responses to treatment without the requirement for liver biopsy,” said Rob Myers, MD, Vice President, Liver Fibrosis Clinical Research at Gilead Sciences. “The ELF Test has proven itself to be a valuable tool in NASH management and we hope this partnership will further support its use in routine care.”  “We are very pleased that NASH patients in the Healthy Nevada Project now have access to the ELF Test which offers clinically useful prognostic information for their condition with the convenience of a simple blood test. Using our advanced laboratory expertise together with Renown IHI and Gilead, we can work towards better understanding of NASH and liver disease in a representative patient population,” said Sebastian Kronmueller, Head of Molecular Diagnostics at Siemens Healthineers. “We launched the Healthy Nevada Project to help people understand more about their health, to identify serious health risks, and to give people access to innovations like the ELF Test, so they can live their best lives,” said Renown’s chief scientific officer, Dr. Joseph Grzymski, who is also a research professor at the Desert Research Institute and principal investigator of the Healthy Nevada Project. It’s incredibly rewarding to be able to report clinical findings to help our 50,000 volunteer study participants, and to assist healthcare providers in helping their patients.” The provision of the ELF Test builds on a previously announced strategic collaboration between the Renown IHI and Gilead in July 2019. This ongoing partnership aims to collect and analyze de-identified genetic and electronic health data from 60,000 qualifying study participants to enhance the understanding of NAFLD and NASH and to potentially inform development of treatment options for these diseases.  About NAFLD and NASH NAFLD is a build-up of fat in the liver of people who do not have a history of alcohol misuse. It is normal for the liver to contain some fat, but if more than 5 percent of the liver content is fat, it’s considered a fatty liver (steatosis). NASH is the most severe form of NAFLD in which a person has liver cell damage and inflammation of the liver. Inflammation and liver cell damage can cause fibrosis, or scarring of the liver, and can cause decreased liver function (1). The symptoms of NASH are often silent or non-specific, making it difficult to diagnose. About one-third of people with NASH develop cirrhosis or irreversible liver damage (2). About the ELF™ Test The ELF Test is a noninvasive blood test that can quickly identify which patients are at an elevated risk for developing cirrhosis and other liver-related clinical events (LREs). In contrast to standard liver enzyme tests that reflect liver damage that has already occurred, the ELF Test combines three serum direct biomarkers of active fibrosis. The ELF Test algorithm measures each of these biomarkers to create an ELF score, which can be used as an aid to assess the risk for future disease progression. Doctors may use this ELF score to help evaluate if a patient requires increased medical care and monitoring for their condition. Individuals interested in determining their risk for NASH and its progression are encouraged to enroll in the Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study. Those who have already consented and participated in the study will be contacted with more information on how to receive an ELF blood test. For more information or to enroll, please contact RenownIHI@renown.org or (775) 982-6914. The Enhanced Liver Fibrosis (ELF™) Test kit is not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.  In the U.S., the ELF Testing Service is available from Siemens Healthcare Laboratory, LLC (SHL), a CLIA-certified laboratory located in Berkeley, Calif. The ELF Testing Service, including the establishment of performance characteristics, was developed by SHL. The ELF Test has not been cleared or approved by the U.S. Food and Drug Administration. SHL is regulated under CLIA as qualified to perform high complexity testing. The ELF Test is used for clinical purposes and should not be regarded as investigational use only or research use only. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Health, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information visit, renown.org. About the Renown Institute for Health Innovation Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org. Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has over 60,000 participants. For more information, visit healthynv.org.  About Siemens Healthineers Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion. Further information is available at www.siemens-healthineers.com.Media Contact for Siemens Healthineers: Lance LongwellM: 610-448-6341E: lance.longwell@siemens-healthineers.com

Read More About Renown Institute Expands Partnership to Offer ELF Testing

Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

Read More About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results